Literature DB >> 30795880

Primary immunodeficiency and autoimmunity: A comprehensive review.

Laura Amaya-Uribe1, Manuel Rojas2, Gholamreza Azizi3, Juan-Manuel Anaya1, M Eric Gershwin4.   

Abstract

The primary immunodeficiency diseases (PIDs) include many genetic disorders that affect different components of the innate and adaptive responses. The number of distinct genetic PIDs has increased exponentially with improved methods of detection and advanced laboratory methodology. Patients with PIDs have an increased susceptibility to infectious diseases and non-infectious complications including allergies, malignancies and autoimmune diseases (ADs), the latter being the first manifestation of PIDs in several cases. There are two types of PIDS. Monogenic immunodeficiencies due to mutations in genes involved in immunological tolerance that increase the predisposition to develop autoimmunity including polyautoimmunity, and polygenic immunodeficiencies characterized by a heterogeneous clinical presentation that can be explained by a complex pathophysiology and which may have a multifactorial etiology. The high prevalence of ADs in PIDs demonstrates the intricate relationships between the mechanisms of these two conditions. Defects in central and peripheral tolerance, including mutations in AIRE and T regulatory cells respectively, are thought to be crucial in the development of ADs in these patients. In fact, pathology that leads to PID often also impacts the Treg/Th17 balance that may ease the appearance of a proinflammatory environment, increasing the odds for the development of autoimmunity. Furthermore, the influence of chronic and recurrent infections through molecular mimicry, bystander activation and super antigens activation are supposed to be pivotal for the development of autoimmunity. These multiple mechanisms are associated with diverse clinical subphenotypes that hinders an accurate diagnosis in clinical settings, and in some cases, may delay the selection of suitable pharmacological therapies. Herein, a comprehensively appraisal of the common mechanisms among these conditions, together with clinical pearls for treatment and diagnosis is presented.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Autoimmunity; Immunodeficiencies; Immunologic deficiency syndromes; Primary immunodeficiency

Mesh:

Substances:

Year:  2019        PMID: 30795880     DOI: 10.1016/j.jaut.2019.01.011

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  30 in total

Review 1.  Beyond Infections: New Warning Signs for Inborn Errors of Immunity in Children.

Authors:  Giorgio Costagliola; Diego G Peroni; Rita Consolini
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

2.  Retrospective study of 98 patients with X-linked agammaglobulinemia complicated with arthritis.

Authors:  Ran Qing-Qi; Li Ya-Wen; Chen Huan; Zhang Yu; An Yun-Fei; Tang Xue-Mei; Zhao Xiao-Dong; Zhang Zhi-Yong
Journal:  Clin Rheumatol       Date:  2022-02-16       Impact factor: 3.650

3.  Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity.

Authors:  Eun Sil Kim; Dongsub Kim; Yoonsun Yoon; Yiyoung Kwon; Sangwoo Park; Jihyun Kim; Kang Mo Ahn; Soomin Ahn; Yon Ho Choe; Yae-Jean Kim; Mi Jin Kim
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

Review 4.  Uveitis: Molecular Pathogenesis and Emerging Therapies.

Authors:  Charles E Egwuagu; Sahar A Alhakeem; Evaristus C Mbanefo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

Review 5.  Autoimmunity as a continuum in primary immunodeficiency.

Authors:  Jolan E Walter; Irmel A Ayala; Diana Milojevic
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

6.  Serum IgG Profiling of Toddlers Reveals a Subgroup with Elevated Seropositive Antibodies to Viruses Correlating with Increased Vaccine and Autoantigen Responses.

Authors:  Patricia Pichilingue-Reto; Prithvi Raj; Quan-Zhen Li; Igor Dozmorov; David R Karp; Edward K Wakeland; Morgan Nelson; Rebecca S Gruchalla; M Teresa de la Morena; Nicolai S C van Oers
Journal:  J Clin Immunol       Date:  2021-03-03       Impact factor: 8.317

Review 7.  The Importance of the Transcription Factor Foxp3 in the Development of Primary Immunodeficiencies.

Authors:  Paulina Mertowska; Sebastian Mertowski; Martyna Podgajna; Ewelina Grywalska
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

8.  A novel mutation in NCF2 resulting in very-early-onset colitis and juvenile idiopathic arthritis in a patient with chronic granulomatous disease.

Authors:  Suzan AlKhater
Journal:  Allergy Asthma Clin Immunol       Date:  2019-11-21       Impact factor: 3.406

9.  T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.

Authors:  Deepak Kumar; Chengyu Prince; Carolyn M Bennett; Michael Briones; Laura Lucas; Athena Russell; Kiran Patel; Satheesh Chonat; Sara Graciaa; Holly Edington; Michael H White; Lisa Kobrynski; Manar Abdalgani; Suhag Parikh; Sharat Chandra; Jack Bleesing; Rebecca Marsh; Sunita Park; Edmund K Waller; Sampath Prahalad; Shanmuganathan Chandrakasan
Journal:  Blood       Date:  2022-01-20       Impact factor: 22.113

Review 10.  Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation.

Authors:  Tarin M Bigley; Megan A Cooper
Journal:  Curr Opin Immunol       Date:  2021-07-12       Impact factor: 7.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.